$Sacubitril/valsartan in patients with heart failure with reduced ejection fraction with end‐stage of renal disease$

Sacubitril/valsartan in patients with heart failure with reduced ejection fraction with end‐stage of renal disease

Abstract Aims Sacubitril/valsartan (SV) reduced heart failure hospitalization and cardiovascular mortality compared with enalapril in the Prospective Comparison of ARNI with ACE‐I to Determine Impact on Global Mortality and Morbidity in Heart Failure trial. However, this trial excluded patients with...

Full description

Saved in:

Bibliographic Details
Main Authors:	Seonhwa Lee, Jaewon Oh, Hyoeun Kim, Jaehyung Ha, Kyeong‐hyeon Chun, Chan Joo Lee, Sungha Park, Sang‐Hak Lee, Seok‐Min Kang
Format:	Article
Language:	English
Published:	Wiley 2020-06-01
Series:	ESC Heart Failure
Subjects:	Sacubitril/valsartan Heart failure with reduced ejection fraction patients End‐stage renal disease Dialysis
Online Access:	https://doi.org/10.1002/ehf2.12659
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

Eligibility for sacubitril–valsartan in patients with acute decompensated heart failure
by: David Carballo, et al.
Published: (2020-06-01)

Sacubitril/valsartan on right ventricular-pulmonary artery coupling and albumin-bilirubin score in heart failure in Chinese patients with reduced ejection fraction
by: Yanan Shi, et al.
Published: (2025-01-01)

Progress in Managing Heart Failure: an in-depth Review of Sacubitril/Valsartan Combination Therapy
by: Neeraj Hiremath, et al.
Published: (2024-04-01)

Left ventricular output indices and sacubitril/valsartan titration: role of stroke volume index
by: Paolo Tolomeo, et al.
Published: (2022-06-01)

Early experience of Sacubitril–Valsartan in heart failure with reduced ejection fraction in real‐world clinical setting
by: Charlotte Nordberg Backelin, et al.
Published: (2020-06-01)

Use of sacubitril/valsartan in non‐compaction cardiomyopathy: a case report
by: Marcely Gimenes Bonatto, et al.
Published: (2020-06-01)

Effect of sacubitril/valsartan on inflammation and oxidative stress in doxorubicin-induced heart failure model in rabbits
by: Yu Chun, et al.
Published: (2021-09-01)

Sacubitril/Valsartan for Blood Pressure Lowering in Non‐Dialysis‐Dependent Chronic Kidney Disease Stage 3–5 Patients With Hypertension: A Multicenter Clinical Study
by: Yu Yan, et al.
Published: (2025-01-01)

The role of sacubitril/valsartan in abnormal renal function patients combined with heart failure: a meta-analysis and systematic analysis
by: Xinyue Yang, et al.
Published: (2024-12-01)

Efficacy and Safety of Sacubitril/Valsartan Versus Amlodipine in Japanese Patients With Essential Hypertension: A Randomized, Multicenter, Open‐Label, Noninferiority Study (PARASOL Study)
by: Koichi Yamamoto, et al.
Published: (2025-01-01)

Short‐term echocardiographic evaluation by global longitudinal strain in patients with heart failure treated with sacubitril/valsartan
by: Simone Mazzetti, et al.
Published: (2020-06-01)

Fulminant myocarditis caused by immune checkpoint inhibitor: a case report and possible treatment inspiration
by: Zhijie Liu, et al.
Published: (2022-06-01)

Heart failure with mildly reduced ejection fraction: retrospective study of ejection fraction trajectory risk
by: Robert J.H. Miller, et al.
Published: (2022-06-01)

Efficacy of vericiguat in patients with chronic heart failure and reduced ejection fraction: a prospective observational study
by: Yinge Zhan, et al.
Published: (2025-02-01)

Spectrophotometric method for simultaneous determination of valsartan and substances from the group of statins in binary mixtures
by: Stolarczyk Mariusz, et al.
Published: (2017-12-01)

Efficacy of sacubitril/valsartan among patients with chronic heart failure with reduced ejection fraction
by: Madiha Butt, et al.
Published: (2024-09-01)

Use of compounded dispersing media for extemporaneous pediatric syrups with candesartan cilexetil and valsartan
by: Musko Monika, et al.
Published: (2014-12-01)

Electrocardiography-based artificial intelligence predicts the upcoming future of heart failure with mildly reduced ejection fraction
by: Dae-Young Kim, et al.
Published: (2025-02-01)

IMPROVING EFFICIENCY OF THE JET PUMP AT LOW COEFFICIENTS OF EJECTION
by: A. G. Butenko, et al.
Published: (2015-06-01)

Impact of Initial Heart Rate, Diastolic Pressure, and Pulse Pressure on Prognostic Outcomes in Heart Failure Patients with Mildly Reduced Ejection Fraction
by: Hu H, et al.
Published: (2025-01-01)

Clinical characteristics and outcomes in Asian patients with heart failure with mildly reduced ejection fraction
by: Julian Cheong Kiat Tay, et al.
Published: (2024-07-01)

Solar Coronal Mass Ejection and Post–Coronal Mass Ejection Blob Formation in Two-fluid Simulations
by: J. C. Du, et al.
Published: (2025-01-01)

Characteristics and Outcomes of Heart Failure Outpatients with Improvement in Ejection Fraction in Qatar
by: Rasha Kaddoura, et al.
Published: (2024-07-01)

Improved cardiac and venous pressures during hospital stay in patients with acute heart failure: an echocardiography and biomarkers study
by: Eiichi Akiyama, et al.
Published: (2020-06-01)

Challenges in the diagnosis of heart failure with preserved ejection fraction in individuals with obesity
by: Bas M. van Dalen, et al.
Published: (2025-02-01)

Prevalence and prognostic value of ventricular conduction delay in heart failure with preserved ejection fraction
by: Anouk Achten, et al.
Published: (2025-04-01)

Evaluation of the relationship between cardiac calcification and cardiovascular disease using the echocardiographic calcium score in patients undergoing peritoneal dialysis: a cross-sectional study
by: Ho-Kwan Sin, et al.
Published: (2023-06-01)

Employment before and after initiation of dialysis or kidney transplantation– a Danish nationwide registry-based cohort study
by: Rasmus Kirkeskov Carlsen, et al.
Published: (2025-01-01)

3D Nonequilibrium Ionization and Spectroscopic Modeling of Coronal Mass Ejections. I. Comparison with Hinode/EIS Observations
by: E. M. Wraback, et al.
Published: (2025-01-01)

Spatial characterization of debris ejection from the interaction of a tightly focused PW-laser pulse with metal targets
by: I.-M. Vladisavlevici, et al.

A Magnetohydrodynamics Simulation of Coronal Mass Ejections in the Upper Corona at 2.5R⊙ ≤ r ≤ 19R⊙
by: Keiji Hayashi, et al.
Published: (2025-01-01)

Outcomes of Worsened Left Ventricular Ejection Fraction After Transcatheter Aortic Valve Replacement
by: Hu Z, et al.
Published: (2025-01-01)

Economic impact of heart failure with preserved ejection fraction: insights from the ALDO‐DHF trial
by: Djawid Hashemi, et al.
Published: (2020-06-01)

Daily home monitoring of potassium, creatinine, and estimated plasma volume in heart failure post‐discharge
by: Patrick Rossignol, et al.
Published: (2020-06-01)

Long-term mortality in patients with end-stage renal disease undergoing hemodialysis and peritoneal dialysis: a propensity score matching retrospective study
by: Pengjie Zhang, et al.
Published: (2024-12-01)

Cost-effectiveness and budget impact analysis of peritoneal dialysis and haemodialysis in South Africa
by: Evelyn Thsehla, et al.
Published: (2025-01-01)

The Effect Of Demographic Factors And Comorbidities On Ejection Fraction Outcome In Acute Myocardial Infarction Patients
by: Kausar Malik, et al.
Published: (2024-09-01)

Rehospitalization burden and morbidity risk in patients with heart failure with mid‐range ejection fraction
by: Enrique Santas, et al.
Published: (2020-06-01)

Clinical characteristics and frailty status in heart failure with preserved vs. reduced ejection fraction
by: Tomoyuki Hamada, et al.
Published: (2022-06-01)

Safety and Tolerability of Initiating Maximum-Dose Sacubitril-Valsartan in Patients on Target Dose Renin-Angiotensin System Inhibitors
by: Helena Norberg, et al.
Published: (2019-01-01)